Skip to content
Medi Assist Healthcare logo

Medi Assist Healthcare Services

MEDIASSIST NSE
₹290.10 No trade today
P/E
23.10
View as Markdown
MCP
Close 4 Nov 2026 ₹290.10 −222.45 −43.4% 1Y
Start ₹512.55

Key Fundamentals

MicrocapInsuranceFinancial Services

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
13.20%
Debt to Equity
0.06
EPS (TTM)
₹12.56
Book Value
₹118.31
Market Cap
—
P/E (TTM)
23.10
P/B
2.45
ROE
13.40%
Dividend Yield
0.69%
EBITDA
₹193 Cr
52W High
₹530.00
52W Low
₹275.50
Volume
0

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

50 Average

Data confidence 100/100

Category scores

Quality
78
Strong
Returns, margins, earnings quality 22% weight
Valuation
53
Average
Cheap vs sector & own history 24% weight
Growth
78
Strong
Sales & profit trajectory 9% weight
Financial Health
71
Strong
Solvency, leverage, coverage 9% weight
Momentum
15
Poor
Trend strength, vol-adjusted 12% weight
Ownership
17
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 24.8%

Weaknesses

2
  • Promoter holding is low: 4.61%
  • Tax rate seems low

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1171
OscillatorsNeutral171
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
40.15
Neutral
MACD (12,26,9)
−6.43
Bullish
SMA (50)
313.77
Bearish
SMA (200)
352.87
Bearish

As of

Analyst Rating

Based on 2 analysts
BUY100%

2 of 2 analysts rate Buy, 0 Hold, 0 Sell.

As of

BUY
2
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+22.88%
3Y+21.47%
1Y+25.17%
TTM+27.44%

Net profit

Net profit growth by window
5Y+27.90%
3Y+6.35%
1Y−3.26%
TTM−2.08%

Operating cash flow

Operating cash flow growth by window
5Y−3.22%
3Y+13.36%
1Y−14.49%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−4.19 pp
3Y−4.42 pp
1Y−1.96 pp
TTM−2.54 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2019₹277 Cr
Mar 2020₹319 Cr
Mar 2021₹323 Cr
Mar 2022₹394 Cr
Mar 2023₹505 Cr
Mar 2024₹635 Cr
Mar 2025₹723 Cr
Mar 2026₹905 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2019₹26.00 Cr
Mar 2020₹35.00 Cr
Mar 2021₹26.00 Cr
Mar 2022₹64.00 Cr
Mar 2023₹74.00 Cr
Mar 2024₹69.00 Cr
Mar 2025₹92.00 Cr
Mar 2026₹89.00 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹224 Cr +15.9% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Generated 6 Jul 2026
AI opinion · based on fundamentals
Risk medium

Medi Assist Healthcare Services is a health insurance TPA/insurtech platform with a market cap of ~₹2,780 crore, trading at a PE of 31.3x. The company delivered FY26 consolidated revenue of ₹905 crore (25% YoY growth) with a 5-year sales CAGR of 23%, though PAT dipped marginally to ₹89 crore in FY26 from ₹92 crore in FY25 and the stock has declined 29% over the past year.

Bull Case 8
  • Strong revenue growth trajectory — FY26 consolidated sales of ₹905 crore, up 25% YoY from ₹723 crore in FY25, with a 5-year compounded sales CAGR of 23%
  • Premium under management reached ₹15,829 crore as of Dec 2024, up 16.6% YoY, providing visibility on future revenue streams
  • Retail premium segment growing at 31.2% YoY (₹2,050 crore), faster than overall group premium growth of 14.7%, indicating diversification
  • Company is almost debt-free with reduced leverage, lowering financial risk and interest burden
  • High group account retention rate of 94.3%, demonstrating client stickiness and recurring revenue characteristics
  • 5-year compounded profit CAGR of 32%, reflecting operating leverage as the business scales
  • Operating EBITDA margin maintained above 19-21% range (FY26 OPM at 18.9%, FY25 at 20.6%), indicating platform scalability
  • Dividend yield of 1.07% with a 17% payout in FY26, signalling improving shareholder returns from a near-zero payout in FY25
Bear Case 8
  • Stock has declined 29% over the past year, significantly underperforming the broader market and eroding investor wealth
  • Promoter holding is extremely low at just 4.61%, raising governance and alignment concerns for minority shareholders
  • FY26 PAT declined to ₹89 crore from ₹92 crore in FY25 despite 25% revenue growth, with OPM compressing from 20.6% to 18.9%
  • TTM profit growth of only 9% versus 25% revenue growth indicates margin pressure and rising costs (depreciation up from ₹56 crore to ₹77 crore in FY26)
  • PE of 31.3x is elevated for a company with single-digit near-term profit growth, implying high expectations are priced in
  • ROE has trended down from 17% (5-year average) to 14% in the last year, suggesting declining capital efficiency
  • Interest costs more than doubled from ₹10.3 crore in FY25 to ₹21.4 crore in FY26, potentially linked to acquisitions or working capital needs
  • Low 3-year average dividend payout of 14.4% of profits, with inconsistent payout history (0% in FY25, 42% in FY24), limiting income-oriented appeal

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

121d ago

TL;DR: Medi Assist is consolidating ownership of its UK subsidiary Mayfair We Care, signaling confidence in international operations. No negative developments reported in this period. The move toward near-full ownership of the UK unit could unlock operational synergies, though the investment size is modest. Trend appears stable with a slight international expansion tilt.

Positives 1
  • Raising stake in UK unit Jun 24

    Medi Assist to acquire 31.75% additional shares in Mayfair We Care Limited for GBP 589,270, increasing holding from 60% to 91.75%, strengthening control over its UK subsidiary.

Quarterly Results

₹ Cr
MEDIASSIST quarterly results, ₹ crore
Particulars Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
136
141
166
167
168
181
186
189
191
233
240
242
237
242
Expenses
105
118
132
130
132
142
146
148
149
193
195
194
189
192
Operating Profit
31
22
34
37
35
38
40
41
42
40
45
48
48
49
OPM %
23%
16%
20%
22%
21%
21%
21%
22%
22%
17%
19%
20%
20%
20%
Other Income
2
5
4
4
5
6
4
8
7
2
−7
1.25
10
—
Interest
1
1
1
1
2
2
2
4
5
8
8
0.65
2
2
Depreciation
8
8
11
12
14
14
14
14
14
21
21
21
22
22
PBT
23
18
26
28
25
29.49
27
30
31
13
8
28
35
30
Tax %
32%
3%
17%
9%
24%
29%
−10%
28%
26%
40%
51%
−95%
21%
27%
Net Profit
16
18
21
26
19
21
30
22
23
8
4
54
28
22
EPS (₹)
2.3
2.58
2.98
3.58
2.68
2.99
4.19
3.05
3.18
1.13
0.56
7.16
3.71
—

Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
MEDIASSIST profit and loss, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
277
319
323
394
505
635
723
905
951
Expenses
194
237
247
302
385
501
569
730
770
Operating Profit
82
82
76
92
120
133
154
175
181
OPM %
30%
26%
23%
23%
24%
21%
21%
19%
19%
Other Income
−14
7
11
21
12
−5
24
4
9
Interest
4
4
6
3
3
3
10
21
20
Depreciation
23
27
32
28
27
43
56
77
85
PBT
41
59
49
81
102
82
112
80
85
Tax %
37%
41%
47%
21%
28%
16%
18%
−11%
—
Net Profit
26
35
26
64
74
69
92
89
94
EPS (₹)
Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank.
Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank.
Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank.
9.33
10.76
9.53
12.89
11.78
12.56
Div. Payout %
0%
0%
0%
20%
18%
26%
31%
17%
—

Balance Sheet

₹ Cr
MEDIASSIST balance sheet, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.04
0.04
0.04
34
34
35
35
37
Reserves
218
212
290
303
342
437
506
802
Borrowings
98
115
35
27
31
26
204
54
Other Liabilities
202
231
220
238
295
344
412
479
Total Liabilities
518
558
545
602
702
842
1,158
1,372
Fixed Assets
142
138
119
99
171
246
306
639
CWIP
3
1
1
6
0
3
4
19
Investments
88
72
111
201
44
77
274
158
Other Assets
285
347
315
296
487
516
574
556
Total Assets
518
558
545
602
702
842
1,158
1,372

Cash Flow

₹ Cr
MEDIASSIST cash flow, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
35
19
139
64
81
66
138
118
Investing
−21
−22
−61
−83
−10
−55
−218
−158
Financing
−10
−12
−10
−30
−32
−15
112
12
Net Cash Flow
4
−15
69
−49
39
−3
32
−28
Free Cash Flow
14
−2
126
62
53
49
92
62
CFO/OP
97
70
141
116
100
70
89
83

Ratios

MEDIASSIST financial ratios, annual
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
119
78
137
110
92
103
112
116
Cash Conversion Cycle
119
78
137
110
92
103
112
116
Working Capital Days
−80
−103
−73
−59
−66
−43
−105
−37
ROCE %
—
20%
19%
23%
26%
23%
19%
13%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medi Assist Healthcare insights

61 extracted metrics across FY19–FY27.

Shareholding Pattern

As of Sep 2026

  • DIIs 46.08%
  • FIIs 24.55%
  • Public 16.75%
  • Others 8.02%
  • Promoters 4.61%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Medi Assist Healthcare Services

What does Medi Assist Healthcare Services Ltd do?
Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.
Where is Medi Assist Healthcare Services Ltd (MEDIASSIST) listed?
Medi Assist Healthcare Services Ltd trades as MEDIASSIST on the NSE and under code 544088 on the BSE.
Which sector does Medi Assist Healthcare Services Ltd belong to?
Medi Assist Healthcare Services Ltd is classified under the Insurance sector, in the Insurance Distribution industry.
What is the PE ratio of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd trades at a PE ratio of 23.10 as of 4 Nov 2026, on earnings per share of ₹12.56, against a book value of ₹118.31 per share.
What is the 52-week high and low of Medi Assist Healthcare Services Ltd?
Over the last 52 weeks Medi Assist Healthcare Services Ltd has traded between ₹275.5 and ₹530 as of 4 Nov 2026.
Does Medi Assist Healthcare Services Ltd pay dividends?
Medi Assist Healthcare Services Ltd has a dividend yield of 0.69%.
What is the Return on Equity (ROE) of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd reported a return on equity of 13.40%. Its debt-to-equity ratio is 0.06.

Company Information

Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.

Website mediassist.in
Listed 23 Jan 2024
Face Value ₹5

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MEDIASSIST.md for Medi Assist Healthcare Services Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Insurance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month